| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.73B | -2.2% |
| Cost of Revenue | $1.87B | -1.7% |
| Gross Profit | $857.4M | -3.3% |
| R&D Expense | $132.1M | +5.8% |
| SG&A Expense | $181.6M | +5.9% |
| Operating Income | $543.7M | -7.8% |
| Interest Expense | $39.7M | -30.8% |
| Pre-tax Income | $560.6M | -4.0% |
| Income Tax | $141.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.6M | +0.2% |
| Accounts Receivable | $422.1M | +6.7% |
| Inventory | $502.3M | -0.6% |
| Current Assets | $1.06B | +2.9% |
| Total Assets | $3.49B | +11.6% |
| Current Liabilities | $419.3M | +12.0% |
| Long-term Debt | $883.4M | -9.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $569.0M | +9.5% |
| Capital Expenditures | $77.6M | +35.4% |
| Investing Cash Flow | -$291.1M | +60.6% |
| Financing Cash Flow | -$279.1M | -250.2% |
| Free Cash Flow | $491.3M | +6.3% |
| +16.5% |
| Net Income | $418.7M | -9.4% |
| EPS (Basic) | $44.44 | -7.8% |
| EPS (Diluted) | $44.44 | -7.8% |
| Total Liabilities |
| $1.71B |
| +2.8% |
| Stockholders' Equity | $1.78B | +21.7% |